Science

Press release:

Marinomed:clinical validation of the Marinosolv® platform Marinomed Biotech AG: Budesolv with a strongly decreased dose of the active ingredient compared to the marketed product Rhinocort Aqua shows pronounced efficacy already after first application – clinical validation of the Marinosolv® platform Marinomed Biotech AG: Budesolv with a strongly decreased dose of the active ingredient compared to the marketed product Rhinocort Aqua shows pronounced efficacy already after first
[more]

Press release:

BioAgilytix Europe appoints new Scientific Officer BioAgilytix, a leading global bioanalytical testing laboratory specializing in the bioanalysis of biopharmaceuticals, is pleased to announce the appointment of its new Scientific Officer for BioAgilytix Europe, Dr Lydia Michaut. Lydia brings a wealth of experience in immunology, genetics, gene therapy and regulated bioanalysis to the company, and is perfectly placed to liaise with clients to ensure that BioAgilytix
[more]

Press release:

HEAVY METALS WEIGH ON UNBORN BABIES’ HEALTH Researchers from Karl Landsteiner University of Health Sciences (Austria) and the Medical University of Vienna explain workings of placental transport systems; spotlight on mercury and iron. Krems (Austria), 19 February 2019 – The toxic heavy metal mercury can find its way into the blood of unborn babies through the placenta by “camouflaging” itself as an amino acid. This finding was
[more]

Press release:

THE WINE DETECTIVES: HIGH-PRECISION CHEMICAL FINGERPRINT ALLOWS UNAMBIGUOUS IDENTIFICATION EQ BOKU at the University of Natural Resources and Life Sciences, Vienna uses high-tech approach to classification of 42 wines Vienna (Austria), 29 January 2019 – Numerous components of 42 different wines have been analysed using state-of-the-art equipment for the first time. The data generated will provide an extremely accurate basis for definitively characterising different wine varieties, as
[more]

Press release:

Certified Quality with vermicon AG vermicon AG‘ s quality management system successfully certified according to ISO 9001 : 2015 Munich, 24. January 2019 - vermicon AG, the specialist for microbiological solutions from Munich, has successfully completed the certification process according to ISO 9001:2015 in November 2018. As a certification body, TÜV Süd Management Service GmbH confirmed vermicon AG‘s high quality standards and the effectiveness of
[more]

Press release:

BREAST CANCER: NEW COMPOUND COULD ENHANCE THE EFFICACY OF STANDARD TREATMENT Physician-scientists from the Karl Landsteiner University of Health Sciences, Krems (Austria) together with colleagues from Germany, US and China demonstrate promising pre-clinical activity of a novel anti-breast cancer drug. Krems (Austria), December 12, 2018 – A novel compound against breast cancer improves the efficacy of standard cancer treatment and shows superior tolerability
[more]

Press release:

AWARD FOR PHAGE THERAPY: PHAGOMED WINS AUSTRIAN ENTREPRENEURSHIP AWARD PHÖNIX Vienna, 4 December 2018: Vienna-based Biotech company PhagoMed Biopharma GmbH was yesterday awarded the Austrian Entrepreneurship Award Phönix 2018 in the category “Start-Up International”. The Phoenix award honours the development of antibiotics alternatives based on phages, a class of natural viruses that only infect bacteria, at the Vienna Biocenter. A distinguished jury selected PhagoMed
[more]

Press release:

Viennese biotech company Marinomed demonstrates the benefits of its patented Marinosolv® technology • Solubilization of the immunomodulator tacrolimus up to 200 times greater using Marinosolv® • Bioavailability in the eye up to 15 times higher under laboratory conditions when compared to commercially available alternative treatments • Findings published in the European Journal of Pharmaceutics and Biopharmaceutics • Clinical trial for Tacrosolv, a tacrolimus-based product candidate against allergic
[more]

Press release:

Psychological intervention study: even brief abstinence from social media causes withdrawal symptoms Researchers from Karl Landsteiner University of Health Sciences identify addiction-like behaviour after time away from social media Krems (Austria), 14 November 2018 – In many cases, just a seven-day break from social media platforms such as Facebook and WhatsApp is sufficient to induce withdrawal symptoms like those caused by addictive substances. This
[more]

Press release:

DONOR ORGANS ON DEMAND: RESEARCH LOOKS AT LIFELIKE ORGAN MODELS PRODUCED ON 3D PRINTERS Biomedical engineers from Karl Landsteiner University of Health Sciences in Krems launch project focused on 3D printing of tissue models Krems, 02 October. 2018 – A research project recently initiated at Karl Landsteiner University of Health Sciences aims to produce organ models with realistic material properties. These biological replicas will mainly be deployed in research and medical training, which will
[more]

Press release:

The Automated Analysis Method for Microbiological Quality Control Munich, 05. September 2018 - As part of the BrauBeviale 2018, vermicon AG presents the powerful Flow VIT® Solution, a combination of flow cytometry and VIT® gene probes technology. Powerful detection system combining VIT® gene probe technology and flow cytometry Flow VIT®: The Automated Analysis Method for Microbiological Quality Control Munich, 05. September 2018 - As part of the
[more]

Press release:

On the "shelf life" of water Hot on the trail of the biostability of water using state-of-the-art DNA and cell analysis Karl Landsteiner University of Health Sciences in Krems launches project to study the growth of water-based microorganisms Krems (Austria), 9 August 2018 – In order to better understand and assess the quality of ground and spring water, state-of-the-art methods from the fields of molecular biology
[more]

Press release:

Pascal Schmidt appointed CFO as Vienna based biotech firm Marinomed strengthens its management team - Company reports strong growth. • Finance expert Pascal Schmidt joins the management team as of August 1, 2018 • Growth trajectory maintained with 84% increase in revenues in 2017 • Significant progression in the development of the Carragelose® and Marinosolv® platforms in 2017 Vienna, July 31, 2018. Vienna based Marinomed Biotech AG (Marinomed) strengthens
[more]

Press release:

explore & share at 9th World Congress on Biopolymers & Bioplastics, London Explore & Share at 9th World Congress on Biopolymers & Bioplastics, London, UK (A solution for Current & Future Global Predicament) August 26-27, 2019 London, UK Since 2016, Biopolymer Congress has been contributing successfully to the global scientific research field. 8th World Congress on Biopolymers & Bioplastics was held during June 28-29, 2018 at Berlin, Germany with the theme “Biopolymer- A Drug
[more]

Press release:

Biotech Company Marinomed Successfully Tests New Combination Drug Against Viral Respiratory Tract Infection • Study delivers initial evidence: single drug could be used to tackle airway infection and reduce inflammation in nasal mucous membrane • Marinomed extends successful application of Carragelose® • Study delivers initial evidence: single drug could be used to tackle airway infection and reduce inflammation in nasal mucous membrane • Marinomed extends successful application of Carragelose® Vienna (Austria), 18 July 2018. Carragelose®, a
[more]

Press release:

Creative Diagnostics Launches IgM Purification Reagents to Support Scientists Focused on Life Science Research Creative Diagnostics launches a new line of ready-to-use, quantitative IgM purification reagents prepared specifically for life science applications. As a leading supplier of research products and custom services, Creative Diagnostics recently has launched a new line of ready-to-use, quantitative IgM purification reagents prepared specifically for life science applications. These new products are available in kit form and loose resin; 1
[more]

Press release:

Antibiotic Targets Vertigo Attacks: Drug Can Be Used to Treat Rare Inner-Ear Condition Karl Landsteiner University of Health Sciences analysed 32 cases from Austria Krems, 3 July 2018 – The antibiotic gentamicin has been used to successfully treat a rare illness that affects the inner ear. This was confirmed by Karl Landsteiner University of Health Sciences’ retrospective evaluation of the results of treatment administered to 32 patients. However, the analysis found that initial
[more]

Press release:

ULTIMATE innovations make Flightpath 2050 targets feasible: Collaborative effort for breakthrough aero engine concepts The European-funded Horizon 2020 ULTIMATE project (Ultra Low emission Technology Innovations for Mid-century Aircraft Turbine Engines) has developed concepts for highly innovative propulsion and integration technologies for mid-century aero engines. With five experienced research groups and four major European engine manufacturers, ULTIMATE partners have identified breakthrough technologies which address the major loss sources in existing aero engines, thus enabling disruptive
[more]

Press release:

Emotions and Gender: Combination of Patient’s and Therapist’s Gender has Impact on Psychotherapy – Including Erotic Feelings Current research findings by Karl Landsteiner University of Health Sciences to be integrated into curriculum Krems, 5 June 2018 – Gender can have an influence on psychotherapy. This is backed up by the latest analysis and long-term research carried out by the director of the Psychotherapy and Counselling Science
[more]

Press release:

HEAR, HEAR! OPTIMISED HEARING DEVICES FEATURING FIBRE-OPTIC TECHNOLOGY MADE IN AUSTRIA Austria-based Karl Landsteiner University of Health Sciences and partners move closer to developing fully implantable hearing aid Krems (Austria), 8 May – Groundbreaking technology for the transmission of acoustic signals, designed for use in fully implantable hearing aids, has been successfully tested for the first time. The technology is based on completely contact-free fibre-optic technology, which senses the tiniest ossicle movements
[more]
Ältere Meldungen